Remdesivir

Alternative Names: Veklury

Remdesivir is an antiviral drug used to treat COVID-19, given through an IV (intravenous infusion), usually over 3 to 5 days. It works by stopping the virus from multiplying in the body. Remdesivir is most effective when started early—within 7 days of symptom onset—and is often used for people who are hospitalized or at high risk for severe illness.

Studies have shown it can shorten recovery time and lower the risk of hospitalization in certain patients. However, it must be given in a clinical setting, which can limit access. Side effects may include nausea, headache, or increased liver enzymes, so monitoring is needed.

Treatment Type: Prescription Medication

Treatment Class: Antiviral

Treatment Modality: Intravenous (IV)

Remdesivir

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the single expert review, intravenous remdesivir appears to be an effective first-line antiviral treatment for hospitalized COVID-19 patients not requiring mechanical ventilation. Administered over 5 days, it has been shown to shorten recovery time, with the greatest efficacy when started within 7 days of symptom onset, although some side effects like nausea and elevated liver enzymes may occur.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
1.0
1 = Very Expensive 5 = Very Affordable

1.0

Very Expensive
Relief Speed
3.0
1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief
Side Effects
3.0
1 = Intolerable Effect 5 = No Effect

3.0

Moderate Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the single expert review, intravenous remdesivir appears to be an effective first-line antiviral treatment for hospitalized COVID-19 patients not requiring mechanical ventilation. Administered over 5 days, it has been shown to shorten recovery time, with the greatest efficacy when started within 7 days of symptom onset, although some side effects like nausea and elevated liver enzymes may occur.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
Remdesivir is the first-line antiviral treatment for hospitalized patients with COVID-19 who are not yet on mechanical ventilation. Administered intravenously over 5 days, it works by inhibiting viral replication and has been shown to shorten recovery time in clinical trials. It is most effective when initiated within 7 days of symptom onset. While generally well tolerated, patients may experience side effects such as nausea or elevated liver enzymes.
#ReviewersPreferred #VeryExpensive #ModerateRelief #ModerateEffect #Second-line #Rescue/EmergencyUse
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All